Regulation of the immune cell glycome in corneal injury
Regulation of the immune cell glycome in corneal injury
批准号:
10591019
负责人:
Pablo Argueso
金额:
$27.8万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-09-01 至 2024-06-30
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary/Abstract
The immune system consists of billions of specialized cells in constant motion that function to maintain
homeostasis within the human body. Among them, monocytes are a population of circulating mononuclear
cells that can cross the vascular endothelium and move into sites if inflammation, where they participate in the
clearance of pathogens and the repairing of damaged tissue. The ability of certain monocytes to express
components of the extracellular matrix defines them as fibrocytes. This cell population has recently come
under intense scrutiny due to their pathological contribution to chronic inflammation and fibrosis in a variety of
organs, including the cornea.
Critical to the functions of the immune cells is the glycocalyx, a diverse mixture of glycans that functions as
the primary interface with the environment. Glycans play a vital role in both the innate and adaptive immune
systems by regulating signaling pathways and the activation of multiple cell types. The Lewis blood group
antigens are among the most important cell surface glycan determinants in immunology, as they promote
interaction with cell adhesion molecules expressed on the surface of endothelial cells. Because of its
significance to the immune reponse, there has been a need for the past few years to define how the glycome
of immune cells is regulated.
It has become increasingly clear that galectins play a critical role as modulators of the immune response.
They can interact with cell surface receptors to promote cell differentiation, affect cell growth and survival, and
modulate cell adhesion. We hypothesize that galectins play a dynamic role in the regulation of the immune
response by directing the immune cell glycome. The following specific aims will address this objective: (1) to
determine whether galectins influence the glycome of human mononuclear cells, (2) to investigate the role of
galectin-3 as a functional regulator of the sialyl Lewis X antigen in activated monocytes, and (3) to investigate
the role of galectin-3-dependent glycosylation in the trafficking and accumulation of corneal fibrocytes. It is
anticipated that this research will have significant translational impact given the impact of circulating fibrocytes
to wound healing and scar formation.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Regulation of the immune cell glycome in corneal injury
-
批准号:10602510
-
项目类别:
-
资助金额:$26.53万
-
财政年份:2020
-
负责人:Pablo Argueso
-
依托单位:
Regulation of the immune cell glycome in corneal injury
-
批准号:10636875
-
项目类别:
-
资助金额:$24.72万
-
财政年份:2020
-
负责人:Pablo Argueso
-
依托单位:
Regulation of the immune cell glycome in corneal injury
-
批准号:10238839
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2020
-
负责人:Pablo Argueso
-
依托单位:
N-Glycosylation and Ocular Surface Homeostasis
-
批准号:10197130
-
项目类别:
-
资助金额:$11.39万
-
财政年份:2016
-
负责人:Pablo Argueso
-
依托单位:
N-Glycosylation and Ocular Surface Homeostasis
-
批准号:10578975
-
项目类别:
-
资助金额:$36.38万
-
财政年份:2016
-
负责人:Pablo Argueso
-
依托单位:
N-Glycosylation and Ocular Surface Homeostasis
-
批准号:9973535
-
项目类别:
-
资助金额:$49.25万
-
财政年份:2016
-
负责人:Pablo Argueso
-
依托单位:
N-glycosylation and ocular surface homeostasis
-
批准号:9533581
-
项目类别:
-
资助金额:$49.25万
-
财政年份:2016
-
负责人:Pablo Argueso
-
依托单位:
N-glycosylation and ocular surface homeostasis
-
批准号:9196100
-
项目类别:
-
资助金额:$49.25万
-
财政年份:2016
-
负责人:Pablo Argueso
-
依托单位:
N-Glycosylation and Ocular Surface Homeostasis
-
批准号:10445276
-
项目类别:
-
资助金额:$43.17万
-
财政年份:2016
-
负责人:Pablo Argueso
-
依托单位:
CD147 and Corneal Wound Repair
-
批准号:8816764
-
项目类别:
-
资助金额:$50.64万
-
财政年份:2015
-
负责人:Pablo Argueso
-
依托单位:
O-Glycans on Mucins at the Ocular Surface
-
批准号:6795401
-
项目类别:
-
资助金额:$32.55万
-
财政年份:2003
-
负责人:Pablo Argueso
-
依托单位:
O-Glycans on Mucins at the Ocular Surface
-
批准号:7117212
-
项目类别:
-
资助金额:$33.49万
-
财政年份:2003
-
负责人:Pablo Argueso
-
依托单位:
O-Glycans on Mucins at the Ocular Surface
-
批准号:8197267
-
项目类别:
-
资助金额:$46.56万
-
财政年份:2003
-
负责人:Pablo Argueso
-
依托单位:
O-Glycans on Mucins at the Ocular Surface
-
批准号:7784789
-
项目类别:
-
资助金额:$48.9万
-
财政年份:2003
-
负责人:Pablo Argueso
-
依托单位:
O-Glycans on Mucins at the Ocular Surface
-
批准号:6670594
-
项目类别:
-
资助金额:$32.55万
-
财政年份:2003
-
负责人:Pablo Argueso
-
依托单位:
O-Glycans on Mucins at the Ocular Surface
-
批准号:6928499
-
项目类别:
-
资助金额:$32.55万
-
财政年份:2003
-
负责人:Pablo Argueso
-
依托单位:
O-Glycans on Mucins at the Ocular Surface
-
批准号:8578100
-
项目类别:
-
资助金额:$45.63万
-
财政年份:2003
-
负责人:Pablo Argueso
-
依托单位:
O-Glycans on Mucins at the Ocular Surface
-
批准号:7281183
-
项目类别:
-
资助金额:$33.31万
-
财政年份:2003
-
负责人:Pablo Argueso
-
依托单位:
O-Glycans on Mucins at the Ocular Surface
-
批准号:8007363
-
项目类别:
-
资助金额:$46.7万
-
财政年份:2003
-
负责人:Pablo Argueso
-
依托单位:
O-Glycans on Mucins at the Ocular Surface
-
批准号:8374122
-
项目类别:
-
资助金额:$44.23万
-
财政年份:2003
-
负责人:Pablo Argueso
-
依托单位:
国内基金
海外基金
登录
查看更多内容
声致离子电流促进小胶质细胞M2极化阻断再生神经瘢痕退变免疫机制
-
批准号:82371973
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:孙迪
-
依托单位:
转运蛋白RCP调控巨噬细胞脂肪酸氧化参与系统性红斑狼疮发病的机制研究
-
批准号:82371798
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:叶俊娜
-
依托单位:
基于FCER1G基因介导免疫反应探讨迟发性聋与认知障碍相关性的机制研究
-
批准号:82371141
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:陈颖
-
依托单位:
CD27-CD28-CD8+T细胞调控儿童肝脏移植免疫耐受形成的作用和机制
-
批准号:82371791
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:刘永波
-
依托单位:
T细胞受体NRP1作为新型免疫检查点在去势抵抗性前列腺癌中的作用机制研究
-
批准号:32100631
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:刘飞
-
依托单位:
抑制FGF19/FGFR4信号通路促进肺鳞癌细胞焦亡及免疫增效的机制研究
-
批准号:32100565
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:李凡
-
依托单位:
自噬基因Epg5在诺如病毒感染过程中的作用
-
批准号:32070745
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2020
-
负责人:路群
-
依托单位:
C9ORF72-SMCR8复合物在小胶质细胞中的功能及其介导的炎症反应
-
批准号:32070743
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2020
-
负责人:杨玫
-
依托单位:
间充质干细胞通过CD73/CD39/腺苷-PI3K/Akt-Nrf2信号轴调节CD4+IL-10+IFN-γ+T细胞分化减弱GVHD机制研究
-
批准号:32070781
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2020
-
负责人:栾希英
-
依托单位:
MET通过MTOR介导的自噬调节肝癌免疫原性和治疗抗性的作用及机制研究
-
批准号:31970696
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2019
-
负责人:黄星
-
依托单位: